$0.70+0.01 (+1.08%)
Retractable Technologies, Inc.
Retractable Technologies, Inc. in the Healthcare sector is trading at $0.70 with a market capitalization of $20M. The stock is currently near its 52-week low of $0.60, remaining 6.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.18Mβ | $9.44Mβ | $10.09Mβ | $10.45Mβ | $8.30M |
| Gross Profit | -$838,408β | -$1.53Mβ | $1.69Mβ | -$107,090β | -$1,911 |
| Operating Income | -$4.69Mβ | -$807,667β | -$3.65Mβ | -$3.66Mβ | -$3.19M |
| Net Income | -$4.23Mβ | -$2.35Mβ | $371,047β | -$87,471β | -$10.50M |
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers...
RVP's first-quarter 2026 sales decline as mix shifts and tariffs pressure pricing, prompting cost cuts and a push to expand domestic production.
Retractable Technologies posts revenue growth, but widening losses, tariff pressures and weak margins underscore ongoing operational challenges and uncertain demand.
Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.
LITTLE ELM, Texas (AP) β Retractable Technologies Inc. RVP) on Thursday reported a loss of $88,000 in its second quarter. On a per-share basis, the Little Elm, Texas-based company said it had a loss of less than 1 cent.